Earn CME credit for this activity: [ Ссылка ]
This on-demand webcast examines recent clinical trial data for novel and emerging therapies, including doublet and triplet combinations for relapsed/refractory disease, and discusses how best to integrate recent therapeutic advances into clinical pathways.
© 2018 NACCME, an HMP Company
